- $10.31bn
- $32.96bn
- $10.82bn
Crescent Biopharma dips on planned equity raise
Brief: Jefferies Shops $5 Billion Debt For Icahn's Possible Caesars Bid - Bloomberg News
Media: Canadian testing company CSA taps Jefferies to explore a sale - Bloomberg News
Nuvation Bio falls on upsized $250 mln convertible bond offering
Nuvation Bio slides on planned $200 mln convertible offering
Taysha Gene Therapies drops on $200 mln stock sale
Jefferies quarterly profit misses estimates as asset management weighs (updated)
Jefferies Financial Group Inc reports results for the quarter ended May 31 - Earnings Summary
Jefferies dips after Q2 results
Jefferies misses revenue estimates in Q2 despite advisory, equities strength
Taysha Gene Therapies slides on $200 mln stock offering launch
Jefferies quarterly profit more than doubles on dealmaking, equities strength
Brief: Jefferies Q2 Revenue USD 2,206.451 Million Vs. IBES Estimate USD 2,299 Million
Brief: Jefferies Says Q2 Revenue $2.21 Billion Versus IBES Estimate $2.3 Billion
U.S. STOCKS ON THE MOVE-Broadcom, Micron, Qualcomm
PREVIEW: Jefferies Q2 EPS, revenue seen rising but shares sink
U.S. STOCKS ON THE MOVE-Kardigan, Energy companies, Take-Two, Accenture
U.S. STOCKS ON THE MOVE-Kardigan, Energy companies
U.S. STOCKS ON THE MOVE-Pfizer, Accenture, Kroger